GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Price-to-Owner-Earnings

Biotage AB (Biotage AB) Price-to-Owner-Earnings : 39.54 (As of May. 01, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Price-to-Owner-Earnings?

As of today (2024-05-01), Biotage AB's share price is $14.63. Biotage AB's Owner Earnings per Share (TTM) ended in Mar. 2024 was $0.37. It's Price-to-Owner-Earnings for today is 39.54.


The historical rank and industry rank for Biotage AB's Price-to-Owner-Earnings or its related term are showing as below:

BITGF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 14.02   Med: 42.66   Max: 77.95
Current: 39.28

During the past 13 years, the highest Price-to-Owner-Earnings of Biotage AB was 77.95. The lowest was 14.02. And the median was 42.66.


BITGF's Price-to-Owner-Earnings is ranked worse than
58.33% of 276 companies
in the Medical Devices & Instruments industry
Industry Median: 33.815 vs BITGF: 39.28

As of today (2024-05-01), Biotage AB's share price is $14.63. Biotage AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.30. Therefore, Biotage AB's PE Ratio for today is 49.09.

As of today (2024-05-01), Biotage AB's share price is $14.63. Biotage AB's EPS without NRI for the trailing twelve months (TTM) ended in was $0.30. Therefore, Biotage AB's PE Ratio without NRI for today is 49.09.

During the past 13 years, Biotage AB's highest PE Ratio without NRI was 90.68. The lowest was 13.20. And the median was 38.85.


Biotage AB Price-to-Owner-Earnings Historical Data

The historical data trend for Biotage AB's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Price-to-Owner-Earnings Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.04 42.11 66.90 43.59 41.38

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.43 41.38 37.12 41.38 42.18

Competitive Comparison of Biotage AB's Price-to-Owner-Earnings

For the Medical Instruments & Supplies subindustry, Biotage AB's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Biotage AB's Price-to-Owner-Earnings falls into.



Biotage AB Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Biotage AB's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=14.63/0.37
=39.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotage AB  (OTCPK:BITGF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Biotage AB Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Biotage AB's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (Biotage AB) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (Biotage AB) Headlines

From GuruFocus

Biotage - Change in number of shares and votes

By PRNewswire PRNewswire 10-29-2021

Biotage AB (publ) Interim report January - September 2021

By PRNewswire PRNewswire 10-28-2021

Biotage AB (publ) Year-end report January - December 2021

By PRNewswire PRNewswire 02-11-2022

Berenberg Bank is now covering Biotage AB (publ) (BIOT)

By PRNewswire PRNewswire 06-29-2021

Biotage appoints Nomination Committee

By PRNewswire PRNewswire 09-24-2020

Biotage AB (publ) Interim report January - June 2021

By PRNewswire PRNewswire 07-16-2021

Biotage - change in number of shares and votes

By PRNewswire PRNewswire 08-31-2020

Biotage AB (publ) Interim report January - March 2021

By PRNewswire PRNewswire 04-28-2021